{
  "main_header": {
    "sid": 10039733,
    "name": "Anlon Healthcare",
    "stock_name": "Anlon Healthcare",
    "full_name": "Anlon Healthcare Ltd",
    "name_url": "stocks-analysis/anlon-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "124.35",
    "chg": 4.25,
    "chgp": "3.54%",
    "dir": 1,
    "prev_price": "120.10",
    "mcapval": "664.00 Cr",
    "mcap": "",
    "scripcode": 544497,
    "symbol": "AHCL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0Y8W01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.29 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/anlon-healthcare-10039733-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039733",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/anlon-healthcare-10039733"
  },
  "announcements": [
    {
      "caption": "Intimation As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations) - Development Of New Product",
      "datetime": "28-Jan-2026",
      "details": "We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund Series I",
      "source": "BSE"
    },
    {
      "caption": "Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025.",
      "datetime": "09-Jan-2026",
      "details": "We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News